CRL 8131

Drug Profile

CRL 8131

Alternative Names: Poloxamer 331; Protox

Latest Information Update: 28 Dec 2000

Price : $50

At a glance

  • Originator CytRx Corporation
  • Class Antibacterials; Antiprotozoals; Antituberculars; Surfactants
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Protozoan infections; Tuberculosis; Viral infections

Most Recent Events

  • 28 Dec 2000 Discontinued-Preclinical for Tuberculosis in USA (Unknown route)
  • 28 Dec 2000 Discontinued-Preclinical for Protozoal infections in USA (Unknown route)
  • 28 Dec 2000 Discontinued-Preclinical for Viral infections in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top